Latest News

Effect of NaCl on pathogenic Th17 cells

 

REPORT FROM THE AMERICAN ACADEMY OF NEUROLOGY (AAN) ANNUAL MEETING, SAN DIEGO, CA, MARCH 16-23, 2013 -High sodium chloride levels promote the differentiation of proinflammatory Th17 cells that are highly pathogenic, according to the preliminary results of an in vitro study in naïve human  CD4+ cells (Kleinewietfeld et al. AAN 2013; abstract S11.004).

Read More

Application to FDA for first-line natalizumab

 

Biogen Idec has applied to the U.S. Food & Drug Administration and the European Medicines Agency to extend the indication for Tysabri (natalizumab) to include first-line use in MS. The first-line indication would be for patients with relapsing MS who had tested negative for JC virus antibodies. At present, the indication for use of natalizumab is as a second-line treatment option for patients who fail prior therapy or have rapidly evolving MS.

Read More

TOPICS:

Tremor- vs. non-tremor-dominant PD: fMRI findings

 

Patients with non-tremor-dominant PD demonstrate reduced brain activity in the prefrontal cortex and globus pallidus compared to tremor-dominant PD and healthy controls, according to the results of a functional MRI study (Prodoehl et al. JAMA Neurol 2013;70:100-106).

Read More

TOPICS:

Drinking water may improve chronic headache

 

A randomized trial has found that increased water intake appears to improve QOL scores in patients with chronic headache (Spigt et al. Fam Pract 2012;29:370-375). A total of 102 patients with chronic headache (>2 moderately intense headaches or >5 mildly intense headaches per month) received usual care (stress reduction, sleep improvement strategies) with or without instructions to drink 1.5 L/day. The primary outcome was change in Migraine-Specific Quality of Life (MSQOL).

Read More